|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. CDC. 2003a. Course: “Smallpox: Disease, Prevention, and Intervention.” Module 5: Smallpox Vaccine Overview. CDC. 2003b. Questions and Answers: Smallpox Vaccination Program Implementation. [Online] Available at http://www.bt.cdc.gov/agent/smallpox/vaccination/vaccination-program-qa.asp. Accessed March 10, 2003. CDC. 2003c. Smallpox Fact Sheet—Information for Clinicians: Smallpox Vaccination Method. CDC. 2003d. Smallpox Vaccination Status and Procedures—Guidelines for Grantees Using Licensed Undiluted Wyeth Dryvax Vaccine. CDC. 2003e. Smallpox Response Plan and Guidelines. Executive Summary. (Updated). CDC. 2003f. Cardiac adverse events following smallpox vaccination—United States, 2003. Morbidity and Mortality Weekly Report 52(12):248-250. CDC. 2003g. Smallpox Fact Sheet: Side Effects of Smallpox Vaccination. [Online] Available at http://www.bt.cdc.gov/agent/smallpox/vaccination/reactions-vacc-public.asp. Accessed September 7, 2004. CDC. 2003h. Smallpox vaccination and adverse reactions: guidance for clinicians. Morbidity and Mortality Weekly Report Dispatch 52:1-29. CDC. 2004. Smallpox Fact Sheet: Vaccine Overview. [Online] Available at http://www.bt.cdc.gov/agent/smallpox/vaccination/facts.asp. Accessed January 26, 2005. CIDRAP (Center for Infectious Disease Research and Policy) and IDSA (Infectious Disease Society of America). 2004. Smallpox: Current, Comprehensive Information on Pathogenesis, Microbiology, Epidemiology, Diagnosis, Treatment, and Prophylaxis. [Online] Available at http://www.cidrap.umn.edu/cidrap/content/bt/smallpox/biofacts/smllpx-summary.html. Accessed August 2004. Cohen J. 2001. Smallpox vaccinations: how much protection remains? Science 294(5544):985. Crotty S, Felgner P, Davies H, Glidewell J, Villarreal L, Ahmed R. 2003. Cutting edge: long-term B cell memory in humans after smallpox vaccination. Journal of Immunology 171(10):4969-4973. DHHS (Department of Health and Human Services). 2001. News Release: HHS Awards $428 Million Contract to Produce Smallpox Vaccine. Acambis/Baxter Will Produce 155 million Doses by End of 2002. [Online] Available at http://www.hhs.gov/news/press/2001pres/20011128.html. Accessed January 26, 2005. DHHS. 2003. FAQs About Smallpox: The Disease and the Vaccine. [Online] Available at http://www.smallpox.gov/QuestionsAnswers.html. Accessed August 1, 2004. Eichner M. 2003. Analysis of historical data suggests long-lasting protective effects of smallpox vaccination. American Journal of Epidemiology 158:717-723. Fauci A. 2003. NIH’s Role in Implementing a Smallpox Vaccination Program. Testimony before the Senate Committee on Appropriations: Subcommittee on Labor, HHS, Education and Related Agencies, January 30, 2003. Fauci AS. 2002. Smallpox vaccination policy—the need for dialogue. New England Journal of Medicine 346(17):1319-1320. FDA (Food and Drug Administration). 2004. Smallpox Vaccines: Questions and Answers. [Online] Available at http://www.fda.gov/cber/vaccine/smallpox.htm#lic. Accessed November 14, 2004. Fenner F, Henderson D, Arita A, Jezek Z, Ladnyi I. 1988. Smallpox and Its Eradication. Geneva: World Health Organization. Frey SE, Couch RB, Tacket CO, Treanor JJ, Wolff M, Newman FK, Atmar RL, Edelman R, Nolan CM, Belshe RB. 2002. Clinical Responses to Undiluted and Diluted Smallpox Vaccine. New England Journal of Medicine 346(17):1265-1274. Gani R, Leach S. 2001. Transmission potential of smallpox in contemporary populations. Nature 414(6865):748-751.
|
|
|||||||||||||||
